Traneksaamhappe pulber

Traneksaamhappe pulbri peamised eelised

• Täpne suunatud mehhanism By competitively inhibiting plasminogen activation, it stabilizes blood clots, achieving highly effective hemostasis without directly activating the coagulation system, thereby reducing the risk of systemic thrombosis.
• Tõenduspõhine ja autoriteetne kinnitus Included in the World Health Organization’s List of Essential Medicines and highly recommended in clinical guidelines across multiple fields, including orthopedics, obstetrics and gynecology, and trauma surgery, it effectively reduces the need for blood transfusions during surgery and lowers trauma mortality rates.
• Laiendatud multifunktsionaalsed eelised It combines skin-lightening properties for treating melasma with anti-inflammatory effects, offers good overall safety, and is rarely associated with serious adverse reactions.

Traneksaamhappe pulbri toime

• Väga tõhus hemostaas By stabilizing fibrin clots through its antifibrinolytic action, it significantly reduces perioperative blood loss and lowers the need for allogeneic blood transfusions; it can significantly improve the survival rate of patients with severe hemorrhage.
• Eritingimuste haldamine See ravim kohtleb menorrhagia, severe epistaxis, and hemoptysis; it also takistab ekstraheerimisjärgne verejooks hemofiiliaga patsientidel ja sekundaarne verejooks pärast traumaatilise eeskambri hemorraagiat
• Nahka kergendav ja põletikuvastane By inhibiting melanocyte activation signals, it improves melasma and post-inflammatory hyperpigmentation; simultaneously, by reducing vascular permeability, it provides adjunctive treatment for hereditary angioedema, urticaria, and similar conditions.

Heavy Metals (Chemical Control)

Mikrobioloogilised testid